Tag: Diabetes: Type I

Tzield targets the autoimmune issues that drive the disease, rather than its symptoms

Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency

Glycated hemoglobin levels lower and time spent in glucose target range greater with use of intermittently scanned CGM versus fingerstick testing

Increased risk persists for up to six months postinfection for pediatric patients aged 0 to 18 years

For children aged 0 to 14 years, incidence of type 1 diabetes was 20 percent higher in 2020 to 2021 than the seven-year average

Highest burden of new cases expected to be in low- and middle-income countries

Patients receiving BIHAP, using both insulin and glucagon, spent more time in euglycemia, less time in hypoglycemia

Percentage of time in target glucose range increased with open-source AID versus sensor-augmented insulin pump

Intensive glucose control for 24 months did not appear to prevent the decline in residual C-peptide secretion

More improvement seen in certain indicators of neurotypical development at six months among adolescents using hybrid closed-loop system